Compare ResMed Inc. (RMD) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Tempus AI — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while Tempus AI trades at $49.09 (market cap $8.69B). The key difference: ResMed Inc. is far larger — about 3.3× Tempus AI's market cap, and ResMed Inc. pays a 1.21% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| RMD | TEM | |
|---|---|---|
Market Cap | $28.81B | $8.69B |
Sector | Health | Broad Market / Factor |
52-Week High | $293.73 | $103.25 |
52-Week Low | $182.82 | $42.37 |
Enterprise Value | $27.99B | $9.37B |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
